Skip to main content
. 2024 Mar 28;150(3):165. doi: 10.1007/s00432-024-05694-6

Table 2.

The main Characteristics of PCa patients included for survival analysis

Number of patients (N) 69
Duration of follow up time (mean, SD) 64.9 ± 25.84
Duration of follow up time (median) 60 months
Number of BCR (%) 25 (36.3%)
Number of metastasis patients (%) 4 (5.7%)
Number of alive patients without any complication (%) 43 (62.3%)
Number of deaths related to PCa (%) 22 (31.8%)

OS overall survival; DSS disease-specific survival; BCR biochemical recurrence